A report by Swiss Re indicates that COVID-19 could cause prolonged excess mortality, potentially up to 3% in the US and 2.5% in the UK by 2033. The primary cause is the lasting impact of COVID-19, including direct deaths and contributions to cardiovascular mortality. Addressing COVID-19’s impact on vulnerable populations is crucial to reducing excess mortality. Insurers need to adapt to these shifts in mortality trends to manage risks effectively.